Clinical trial
Investigation of the Safety and Performance of the NVT ALLEGRA THV System With a New Delivery System in Patients With Severe Calcified Aortic Stenosis or Failed Surgical Aortic Bioprosthesis
NCT05478161 is registered in ClinicalTrials.gov with NVT GmbH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Investigation of the Safety and Performance of the NVT ALLEGRA THV System With a New Delivery System in Patients With Severe Calcified Aortic Stenosis or Failed Surgical Aortic Bioprosthesis
- Lead sponsor
- NVT GmbH
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 24, 2023
- Completion date
- December 17, 2024
- Enrollment
- 137 (actual)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.
transcatheter aortic valve implantation